Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Systematic Reviews
Published in: Systematic Reviews 1/2017

Open Access 01-12-2017 | Protocol

Comparative safety and efficacy of pharmacological and non-pharmacological interventions for the behavioral and psychological symptoms of dementia: protocol for a systematic review and network meta-analysis

Authors: Jennifer Watt, Zahra Goodarzi, Andrea C. Tricco, Areti-Angeliki Veroniki, Sharon E. Straus

Published in: Systematic Reviews | Issue 1/2017

Login to get access

Abstract

Background

Behavioral and psychological symptoms of dementia (BPSD) are highly prevalent in patients with dementia. Both pharmacological and non-pharmacological strategies are commonly used to treat these symptoms, but their comparative safety and efficacy is unknown.

Methods

We will conduct a systematic review of the published and unpublished literature to retrieve all articles pertaining to outcomes of safety and efficacy associated with pharmacological and non-pharmacological treatments of BPSD for patients living in the community and institutionalized care settings. Our primary outcome of efficacy is a change in aggression. Our primary outcome of safety will be risk of fracture. These primary outcomes were chosen by stakeholders involved in the care of patients experiencing BPSD. Possible secondary outcomes of efficacy will include a change in agitation, depressive symptoms, and night-time behaviors. Possible secondary outcomes of safety will include the risk of stroke, falls, and mortality. All article screening, data abstraction, and risk of bias appraisal will be completed independently by two reviewers. If the assumption of transitivity is valid and the evidence forms a connected network, Bayesian random-effects pairwise and network meta-analyses (NMAs) will be conducted. Relative treatment rankings will be reported with mean ranks and the surface under the cumulative ranking curve.

Discussion

We will identify the safest and most efficacious treatment strategies for patients with BPSD from among our most highly ranked treatments. The results of this study will be used to guide decision-making and improve patient care.

Systematic review registration

PROSPERO registry number CRD42017050130.
Appendix
Available only for authorised users
Literature
1.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.
2.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer's and Dementia. 2013;9:63–75.CrossRefPubMed
3.
Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288:1475–83.CrossRefPubMed
4.
Cummings JL. The neuropsychiatry inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(S6):S10–S6.CrossRefPubMed
5.
Gonzalez-Salvador M, Arango C, Lyketsos CG, Barba AC. The stress and psychological morbidity of the Alzheimer patient caregiver. International Journal of Geriatric Psychiatry. 1999;14(9):701–10.CrossRefPubMed
6.
7.
Majic T, Gutzmann H, Heinz A, Lang UA, Rapp MA. Animal-assisted therapy and agitation and depression in nursing home residents with dementia: a matched case-control trial. Am J Geriatr Psychiatr. 2013;21(11):1052–9.CrossRef
8.
Barnes TRE, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry. 2012;201:221–6.CrossRefPubMed
9.
Azermai M, Petrovic M, Elseviers MM, Bourgeois J, Van Bortel LM, Vander Stichele RH. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res Rev. 2012;11(1):78–86.CrossRefPubMed
10.
Pariente A, Fourrier-Reglat A, Ducruet T, Farrington P, Beland S-G, Dartigues J-F, et al. Antipsychotic use and myocardial infarction in older adults with treated dementia. Arch Intern Med. 2012;172(8):648–53.CrossRefPubMed
11.
12.
Fraser L-A, Liu K, Naylor KL, Hwang YJ, Dixon SN, Shariff SZ, et al. Falls and fractures with atypical antipsychotic medication use: a population-based cohort study. JAMA Intern Med. 2015;175(3):450–2.CrossRefPubMed
13.
Hwang YJ, Dixon SN, Reiss JP, Wald R, Parikh CR, Gandhi S, et al. Atypical antipsychotic drugs and the risk of acute kidney injury and other adverse outcomes in older adults. Ann Intern Med. 2014;161:242–8.CrossRefPubMed
14.
Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH. Risk of death in elderly uesrs of conventional vs. atypical antipsychotic medications. NEJM. 2005;353(22):2335–41.CrossRefPubMed
15.
Kales HC, Zivin K, Kim HM, Valenstein M, Chiang C, Ignacio RV, et al. Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry. 2011;68(2):190–7.CrossRefPubMed
16.
Moore A, Patterson C, Lee L, Vedel I, Bergman H. Fourth Canadian consensus conference on the diagnosis and treatment of dementia: recommendations for family physicians. Can Fam Physician. 2014;60:433–8.PubMedPubMedCentral
17.
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.CrossRefPubMed
18.
Jansen JP, Trikalinos T, Cappelleri JC, Daw J, Andes S, Eldessouki R, et al. Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NGC good practice task force report. Value Health. 2014;17:157–73.CrossRefPubMed
19.
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777–84.CrossRefPubMed
20.
Cameron C, Fireman B, Hutton B, Clifford T, Coyle D, Wells G, et al. Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities. Systematic Reviews. 2015;4:147.CrossRefPubMedPubMedCentral
21.
Efthimiou O, Mavridis D, Debray TPA, Samara M, Belger M, Siontis GCM, et al. Combining randomized and non-randomized evidence in network meta-analysis. Stat Med. 2017;36(8):1210–26.CrossRefPubMed
22.
PRESS. Peer review of electronic search strategies: 2015 guideline explanation and elaboration (PRESS E&E). CADTH: Ottawa; 2016.
23.
Tricco AC, Ashoor HM, Cardoso R, MacDonald H, Cogo E, Kastner M, et al. Sustainability of knowledge translation interventions in healthcare decision-making: a scoping review. Implement Sci. 2016;11:55.CrossRefPubMedPubMedCentral
24.
Porsteinsson AP, Drye LT, Pollock BG, Devenand DP, Frangakis C. Effect of Citalopram on agitation in Alzheimer's disease: the CitAD randomized controlled trial. JAMA. 2014;311(7):682–91.CrossRefPubMedPubMedCentral
25.
Gitlin LN, Winter L, Dennis MP, Hodgson N, Hauck WW. A Biobehavioural home-based intervention and the well-being of patients with dementia and their caregivers. JAMA. 2010;304(9):983–91.CrossRefPubMedPubMedCentral
26.
Michie S, Johnson M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Quality & safety in health care. 2005;14:26–33.CrossRef
27.
28.
29.
30.
Gill SS, Bronskill SE, Normand S-LT. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146:775–86.CrossRefPubMed
31.
32.
Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N. Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol. 2005;20:49–52.CrossRefPubMed
33.
34.
Johnston BC, Alonso-Coello P, Friedrich JO, Mustafa RA, Tikkinen KAO, Neumann I, et al. Do clinicians understand the size of treatment effects? A randomized survey across 8 countries. CMAJ. 2016;188:25–32.CrossRefPubMed
35.
Caddy C, Amit BH, McCloud TL, Rendell JM, Furukawa TA. Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev. 2015;2015:9.
36.
Rao J, Scott A. A simple method for the analysis of clustered binary data. Biometrics. 1992;48(2):577–85.CrossRefPubMed
37.
Spineli LM, Higgins JPT, Cipriani A, Salanti G. Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis. Clinical Trials. 2013;10:378–88.CrossRefPubMed
38.
Mavridis D, White IR, Higgins JPT, Cipriani A, Salanti G. Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis. Stat Med. 2015;34:721–41.CrossRefPubMed
39.
Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol. 2006;59:7–10.CrossRefPubMed
40.
Jansen JP, Naci H. Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med. 2013;11
41.
Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Research Synthesis Methods. 2012;3:80–97.CrossRefPubMed
42.
Salanti G, Marinho V, Higgins JPT. A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol. 2009;62:857–64.CrossRefPubMed
43.
Schmitz S, Adams R, Walsh C. Incorporating data from various trial designs into a mixed treatment comparison model. Stat Med. 2013;32:2935–49.CrossRefPubMed
44.
Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res. 2001;10(4):277–303.
45.
Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for Pairwise nad network meta-analysis of randomized controlled trials. Med Decis Mak. 2013;33:607–17.CrossRef
46.
Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc. 2002;64(4):583–639.CrossRef
47.
Plummer M. JAGS: a program for analysis of Bayesian graphical models using Gibbs sampling 2003.
48.
Salanti G, Ades AE, Ioannidis JPA. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163–71.CrossRefPubMed
49.
Trinquart L, Attiche N, Bafeta A, Porcher R, Ravaud P. Uncertainty in treatment rankings: reanalysis of network meta-analyses of randomized trials. Ann Intern Med. 2016;164:666–73.CrossRefPubMed
50.
Leucht S, Cipriani A, Spineli L, Mavridis D. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951–62.CrossRefPubMed
51.
Veroniki AA, Straus S, Fyraridis A, Tricco AC. The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes. J Clin Epidemiol. 2016;76:193–9.CrossRefPubMed
52.
Higgins JPT, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Research Synthesis Methods. 2012;3:98–110.CrossRefPubMedPubMedCentral
53.
Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Mak. 2013;33:641–56.CrossRef
54.
Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50(6):683–91.CrossRefPubMed
55.
56.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61:991–6.CrossRefPubMed
57.
Chaimani A, Salanti G. Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions. Research Synthesis Methods. 2012;3:161–76.CrossRefPubMed
58.
Gagliardi AR, Berta W, Boyko J, Urquhart R. Integrated knowledge translation (IKT) in health care: a scoping review. Implement Sci. 2016;11
59.
Knowledge Translation in Health Care. Moving evidence to practice. 2nd ed. Chichester: Wiley; 2013.
60.
Barber CE, Pasley BK. Family Care of Alzheimer's patients: the role of gender and generational relationship on caregiver outcomes. The Journal of Applied Gerontology. 1995;14(2):172–92.CrossRef
61.
McCarron CE, Pullenayegum EM, Thabane L, Goeree R, Tarride J-E. The importance of adjusting for potential confounders in Bayesian hierarchical models synthesizing evidence from randomized and non-randomized studies: an application comparing treatments for abdominal aortic aneurysms. BMC Med Res Methodol. 2010;10:64.CrossRefPubMedPubMedCentral
62.
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome (review). Cochrane Database Syst Rev. 2012;2012:12.
63.
Tricco AC, Cogo E, Holyrod-Leduc J, Sibley KM, Feldman F, Kerr G, et al. Efficacy of falls prevention interventions: protocol for a systematic review and network meta-analysis. Systematic Reviews. 2013;2:38.CrossRefPubMedPubMedCentral
64.
Welton NJ, Caldwell DM, Adamopoulos E, Vedara K. Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol. 2009;169(9):1158–65.CrossRefPubMed
Metadata
Title
Comparative safety and efficacy of pharmacological and non-pharmacological interventions for the behavioral and psychological symptoms of dementia: protocol for a systematic review and network meta-analysis
Authors
Jennifer Watt
Zahra Goodarzi
Andrea C. Tricco
Areti-Angeliki Veroniki
Sharon E. Straus
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2017
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-017-0572-x

Other articles of this Issue 1/2017

Systematic Reviews 1/2017 Go to the issue

Protocol

Patient- and family-centered performance measures focused on actionable processes of care for persistent and chronic critical illness: protocol for a systematic review

Protocol

Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysis

Protocol

Paraquat and Parkinson’s disease: a systematic review protocol according to the OHAT approach for hazard identification

Protocol

Social determinants of common metabolic risk factors (high blood pressure, high blood sugar, high body mass index and high waist-hip ratio) of major non-communicable diseases in South Asia region: a systematic review protocol

Protocol

Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies

Research

Fit for purpose: perspectives on rapid reviews from end-user interviews